Palomar Holdings (PLMR) has just combined a record quarter with a new capital return approach, raising its full year outlook while introducing a US$0.45 quarterly dividend and continuing share repurchases.

Palomar Holdings' recent earnings beat, dividend initiation and ongoing buybacks have come alongside a 90 day share price return of 20.7% and a 1 year total shareholder return of 11.34%. The 3 year total shareholder return of 140.46% points to momentum that has built over a longer period, despite a softer 30 day share price return of 5.83%.

If this combination of growth and capital returns has your attention, it can be useful to widen your view beyond one insurer and check out 20 top founder-led companies

After a record quarter, a new US$0.45 dividend and recent share price cooling, Palomar Holdings now sits at an interesting crossroads. Does it make sense to pay up today or wait for a sharper pullback before buying in?

Most Popular Narrative: 15.1% Undervalued

The most followed narrative on Palomar Holdings puts fair value at $161.17 per share compared with the latest close at $136.82. This frames the current debate around upside versus risk.

Improved reinsurance terms, proactive risk management, and capital strength (including a $150M buyback program) enable Palomar to maintain conservative retentions while locking in favorable reinsurance economics through 2026, underpinning future earnings stability and supporting continued growth in book value and return on equity.

Want to understand why this narrative still sees room above today’s price? It leans heavily on compounded revenue growth, resilient margins and a richer future earnings multiple.

Result: Fair Value of $161.17 (UNDERVALUED)

However, this narrative can quickly change if catastrophe losses spike or if reinsurance becomes more expensive or harder to secure for Palomar Holdings.

Another View On Palomar Holdings Using Market Multiples

The narrative above leans on discounted cash flows and a fair value of $161.17 for Palomar Holdings. Market pricing tells a different story. The stock trades on a P/E of 17.6x, while the US Insurance industry sits at 11.8x, peers at 8.5x and the fair ratio is 14.5x. That premium raises a simple question. Is the higher multiple a reasonable price for quality, or a sign you are paying up for growth that may already be in the share price?

To see how this compares to other valuation checks and where the ratio could move over time, take a closer look at See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Does this mix of enthusiasm and caution around Palomar Holdings match your own view, or does it feel stretched? Act quickly, review the data for yourself, and pressure test both sides of the argument with 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Palomar Holdings?

If Palomar Holdings has sharpened your focus, do not stop here. Use the Simply Wall Street Screener to surface other stocks that fit your style and risk comfort.

• Target reliable cash generators and steady operations by scanning companies in the solid balance sheet and fundamentals stocks screener (49 results).
• Hunt for potential value opportunities by reviewing the 50 high quality undervalued stocks that align with your return and quality expectations.
• Spot early movers that the market may be overlooking by checking the screener containing 19 high quality undiscovered gems before attention shifts their way.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.